influenza
viru
iav
respons
annual
epidem
caus
major
challeng
term
morbid
mortal
iav
pandem
claim
million
death
worldwid
past
thu
iav
major
public
health
threat
identifi
host
cell
factor
compon
exploit
viru
promot
replic
might
offer
target
develop
novel
strategi
treatment
comprehens
knowledg
underli
mechan
pathogenhost
interact
induct
antivir
host
innat
immun
respons
crucial
upon
initi
cell
attach
via
bind
iav
glycoprotein
hemagglutinin
ha
sialic
acid
residu
host
cell
surfac
protein
viral
particl
util
cellular
endocyt
machineri
enter
target
cell
virus
subsequ
traffick
earli
endosom
ee
late
endosomeslysosom
lel
endosom
escap
thought
occur
prerequisit
effici
releas
viral
genom
host
cell
cytoplasm
fusion
viral
envelop
endosom
membran
trigger
acid
condit
within
lel
lower
ph
lead
conform
chang
ha
subsequ
hydrophob
interact
ha
endosom
membran
caus
format
fusion
pore
allow
cytosol
entri
transport
viral
ribonucleoprotein
nucleu
detect
viral
compon
infect
cell
via
host
innat
immun
system
elicit
rapid
induct
secret
antivir
interferon
ifn
cytokin
famili
lead
subsequ
upregul
plethora
gene
help
restrict
iav
infect
spread
ifninduc
elev
level
antivir
protein
demonstr
interfer
fusion
viral
envelop
lel
membran
interestingli
cell
ectop
express
also
show
aberr
late
endosom
accumul
cholesterol
lipid
known
control
membran
sort
dynam
compart
thu
suggest
lel
cholesterol
accumul
link
antivir
activ
lel
membran
properti
howev
relev
alter
endosom
cholesterol
level
viral
restrict
heavili
disput
issu
whether
treatment
interferon
beta
induc
chang
subcellular
cholesterol
pool
address
far
previou
result
indic
strong
impact
balanc
endosom
cholesterol
releas
infect
iav
progeni
therefor
systemat
evalu
impact
enhanc
lel
cholesterol
content
context
host
cell
antivir
respons
report
lel
cholesterol
accumul
alreadi
interfer
iav
infect
earli
step
endosom
escap
thu
contribut
ifninduc
host
cell
defens
incom
iav
protect
function
promot
via
address
issu
whether
block
lel
cholesterol
egress
act
cellular
restrict
factor
iav
replic
independ
axi
induc
lel
cholesterol
accumul
either
pharmacolog
inhibit
lel
cholesterol
transport
protein
affect
niemannpick
diseas
via
overexpress
lel
cholesterol
balanc
protein
annexin
result
phenotyp
reminisc
defici
review
refer
show
ifnindepend
lel
cholesterol
accumul
affect
iav
endosom
traffick
impair
iav
cytosol
entri
like
step
iavendosom
membran
hemifus
ie
lipid
mix
prior
releas
actual
viral
content
occur
thu
data
support
model
lel
cholesterol
accumul
novel
antivir
barrier
put
druggabl
host
cell
factor
iav
infect
assess
role
lel
cholesterol
host
cell
factor
first
determin
whether
induc
chang
lel
cholesterol
pool
therefor
use
filipin
highli
fluoresc
polyen
specif
bind
free
cholesterol
well
establish
histochem
marker
detect
unesterifi
cellular
cholesterol
filipin
stain
plasma
membran
well
intracellular
compart
wildtyp
control
cell
wherea
cholesterol
promin
detect
vesicular
structur
perinuclear
region
cell
ngml
h
especi
evid
heat
map
represent
pixel
px
encod
differ
color
due
intens
fig
verifi
stronger
perinuclear
filipin
signal
due
elev
level
lel
cholesterol
rather
gener
expans
compart
next
determin
degre
overlap
lysotrack
red
signal
filipin
signal
use
mander
coeffici
method
identifi
pixel
doubli
posit
signal
calcul
ratio
sum
signal
intens
one
channel
total
intens
channel
thu
greater
coeffici
good
indic
greater
number
doubli
posit
pixel
analysi
perform
zstack
acquir
confoc
microscopi
axial
dimens
pixel
ad
thu
includ
entir
volum
cell
shown
fig
quantit
coloc
analysi
confirm
significantli
higher
number
lysotrackerposit
pixel
also
posit
filipin
ifntreat
cell
control
cell
similar
result
obtain
coloc
analysi
perform
use
marker
lel
see
fig
supplement
materi
underscor
idea
cholesterol
pool
inde
increas
lel
upon
ifn
exposur
addit
relat
number
voxel
posit
filipin
lysotrack
signal
total
number
lysotrackerposit
voxel
lel
marker
ratio
increas
ifn
treatment
indic
higher
number
filipinposit
voxel
also
posit
lel
marker
regardless
intens
filipin
signal
strength
fig
overexpress
ifninduc
antivir
protein
link
lel
cholesterol
accumul
yet
function
relev
link
especi
context
ifndriven
viral
restrict
fulli
understood
function
dissect
impact
lel
cholesterol
assess
whether
ifndriven
increas
lel
cholesterol
pool
still
present
knockout
cell
gener
system
notabl
cell
abl
respond
ifn
assess
ifnmedi
induct
yet
complet
devoid
even
ifn
stimul
condit
fig
contrast
homolog
protein
display
sequenc
similar
also
coloc
lysosom
still
upregul
ifnstimul
cell
yet
level
upregul
moder
fig
although
also
report
induc
cholesterol
accumul
endosom
weak
ifnstimul
induct
previous
observ
cell
line
compens
loss
cell
accumul
lel
cholesterol
upon
ifn
treatment
fig
consist
coloc
filipin
lysotrack
signal
significantli
decreas
cell
ifn
treatment
fig
substanti
observ
biochem
quantifi
compar
cholesterol
level
cell
fraction
enrich
either
earli
endosom
lel
sucros
gradient
flotat
separ
untreat
ifnexpos
cell
shown
fig
ifntreat
cell
cholesterol
amount
postnuclear
supernat
earli
endosom
fraction
significantli
alter
upon
ifn
treatment
howev
ifntreat
cell
significantli
cholesterol
lelenrich
fraction
seen
untreat
cell
wherea
cell
increas
observ
fraction
line
result
obtain
quantit
coloc
analysi
togeth
result
show
ifn
induc
retent
cholesterol
within
lel
underscor
import
ifndriven
upregul
process
therebi
confirm
previou
report
interestingli
observ
lysotrackerposit
compart
cluster
ifntreat
cell
wherea
fail
ifntreat
cell
howev
cell
display
gener
defect
endosom
reposit
cluster
filipinposit
endosom
seen
upon
treatment
hydrophob
polyamin
cellperm
smallmolecul
inhibitor
endosom
cholesterol
transport
wide
use
pharmacolog
model
induc
lossoffunct
phenotyp
lel
cholesterol
accumul
fig
observ
indic
endosom
cluster
seen
upon
ifn
treatment
depend
increas
lel
cholesterol
load
next
overexpress
shown
fig
overexpress
rest
cell
alter
intracellular
distribut
acid
endosom
howev
ifninduc
lel
cluster
clearli
affect
ifntreat
cell
transfect
display
lel
distribut
resembl
untreat
cell
ifninduc
cluster
clearli
recogniz
green
fluoresc
protein
gfp
transfect
control
cell
check
whether
lel
cell
show
ifninduc
cluster
reposit
forc
lel
cholesterol
load
treat
cell
line
notion
ifninduc
lel
cholesterol
accumul
reason
lel
cluster
cell
show
similar
redistribut
lysotrackerposit
endosom
treatment
fig
substanti
import
endosom
cholesterol
level
lel
posit
studi
distribut
acid
endosom
systemat
therefor
use
softwareassist
imag
analysi
quantifi
number
neighbor
within
radiu
lysotrackerposit
endosom
individu
cell
shown
fig
endosom
ifntreat
cell
tend
greater
number
neighbor
ie
dens
crowd
acid
endosom
untreat
cell
similarli
cell
number
neighbor
per
acid
endosom
increas
summari
result
clearli
show
depend
lel
posit
lel
cholesterol
content
assess
whether
ifninduc
increas
lel
cholesterol
level
side
effect
vital
part
ifn
antivir
protect
investig
lel
cholesterol
imbal
independ
ifn
analysi
physiolog
function
earli
stage
infect
aim
impair
egress
cholesterol
lel
focu
earli
infect
determin
proport
infect
cell
within
first
replic
cycl
therefor
nuclei
infect
cell
analyz
h
postinfect
pi
appear
viral
nucleoprotein
np
predominantli
nuclear
stage
infect
cycl
key
element
cholesterol
transport
compart
cellular
destin
increas
cholesterol
level
first
induc
via
overexpress
neg
regul
expect
high
proport
gfpposit
control
cell
infect
reveal
nuclear
appear
np
contrast
much
lower
number
cell
ectop
overexpress
np
posit
line
notion
enhanc
lel
cholesterol
neg
affect
iav
earli
infect
proport
infect
cell
strongli
increas
transient
coexpress
togeth
cell
fig
valid
find
next
employ
establish
cell
model
consist
parent
cell
line
natur
lack
endogen
cell
line
engin
stabli
express
thu
show
excess
lel
cholesterol
cell
line
infect
monitor
np
stain
h
pi
shown
fig
number
cell
npposit
nuclei
decreas
approxim
cell
compar
cell
strikingli
ectop
express
wt
cell
chang
percentag
infect
cell
wherea
cell
express
almost
complet
rescu
reduc
proport
infect
cell
singl
cycl
fig
suggest
optim
concentr
cholesterol
lel
membran
requir
effici
earli
infect
next
compar
number
npposit
cell
cell
ectop
express
tag
cholesterol
transport
empti
vector
gfp
expect
infect
nontreat
cell
express
gfp
yield
high
number
infect
cell
wherea
pretreat
drastic
reduc
number
npposit
nuclei
fig
note
overexpress
significantli
increas
amount
npposit
nuclei
cell
thu
overexpress
counteract
hostprotect
role
ifn
support
idea
increas
lel
cholesterol
part
innat
immun
respons
iav
second
experiment
approach
treat
cell
inhibitor
exclud
possibl
effect
due
induct
cholesterol
imbal
cell
investig
parallel
proport
infect
cell
increas
cell
lower
viru
titer
use
order
maintain
dynam
assay
window
also
cell
drastic
reduc
number
npposit
nuclei
detect
cell
fig
importantli
treatment
neg
effect
earli
iav
infect
cell
abl
accumul
cholesterol
lel
condit
treatment
see
fig
indic
lel
cholesterol
accumul
exert
hostprotect
function
independ
induct
shown
fig
concentr
use
induc
lel
cholesterol
accumul
affect
endosom
low
ph
key
factor
iav
cell
entri
similarli
overexpress
fig
fig
effect
endosom
acidif
indic
observ
viral
restrict
situat
character
elev
lel
cholesterol
content
caus
impair
endosom
acidif
summari
cell
either
express
treatment
cholesterol
imbal
lel
compart
restrict
first
infect
cycl
incom
iav
particl
independ
antivir
properti
unravel
detail
actual
step
neg
affect
increas
lel
cholesterol
level
first
perform
acidbypass
infect
assay
techniqu
forc
fusion
iav
particl
host
cell
plasma
membran
lead
direct
transfer
viral
genom
cytosol
thu
circumv
endocyt
pathway
strikingli
differ
number
infect
cell
fig
suggest
lel
cholesterol
accumul
act
endosom
uptak
iav
next
perform
comprehens
analysi
sequenti
event
hostcel
entri
line
previou
work
level
effici
iav
endosom
uptak
judg
level
virionassoci
matrix
protein
similar
cell
fig
acid
environ
encount
lel
induc
conform
chang
ha
critic
affect
fusogen
capac
next
use
antibodi
specif
fusionact
conform
expect
find
indic
lel
ph
affect
signific
differ
amount
signal
detect
cell
fig
contrast
hardli
signal
could
detect
cell
treat
bafilomycin
inhibitor
vacuolar
atpas
requir
endosom
acidif
therefor
serv
posit
control
transfer
viral
genom
cytosol
occur
passag
late
endosom
compart
henc
specul
lel
cholesterol
imbal
might
interfer
viral
uncoat
andor
membran
fusion
therefor
viral
envelopeendosom
membran
fusion
assay
util
iav
particl
label
two
lipophil
dye
oxacarbocyanin
octadecyl
rhodamin
b
chlorid
initi
describ
sakai
et
al
employ
identifi
potenti
fusion
defect
upon
fusion
dye
diffus
viral
envelop
endosom
membran
lead
dequench
subsequ
increas
fluoresc
elev
signal
decreas
infect
cell
transient
overexpress
compar
nontransfect
control
cell
verifi
assay
suit
detect
antivir
restrict
host
cell
factor
fig
bafilomycin
block
endosom
acidif
essenti
prerequisit
success
iav
membran
fusion
almost
complet
abolish
dequench
cell
fig
remark
ifn
treatment
result
decreas
dequench
cell
wherea
cell
opposit
effect
ie
increas
dequench
found
importantli
cell
line
treatment
significantli
caus
pronounc
decreas
dequench
indic
iav
membran
fusion
within
cholesterolladen
endosom
impair
similar
result
observ
cell
cell
compar
iavendosom
fusion
impair
viru
fusion
cholesterolladen
endosom
membran
still
observ
cell
subject
small
interf
rna
sirna
treatment
silenc
express
fig
result
contradict
previous
publish
find
impact
lel
cholesterol
viral
envelopeendosom
membran
fusion
appli
respect
singledy
dequench
approach
use
studi
desai
et
al
notabl
assay
neither
use
use
yield
signific
differ
effici
iavendosom
membran
fusion
cell
cell
although
robust
bafilomycin
inhibit
could
detect
fig
suggest
singledy
fusion
assay
display
reduc
sensit
order
investig
influenc
pharmacolog
increas
lel
cholesterol
level
detail
follow
progress
fusion
time
fig
cell
show
lower
valu
time
measur
h
infect
howev
analysi
dequench
rate
reveal
increas
signal
intens
approxim
parallel
case
like
reflect
wellknown
fact
bulk
fusion
occur
within
first
hour
infect
propag
dye
host
membran
fusion
disturb
thu
result
point
inhibitori
effect
lel
cholesterol
viral
envelopeendosom
membran
fusion
support
find
indic
lel
cholesterol
accumul
effici
restrict
factor
oper
step
endosom
escap
independ
solid
bodi
evid
support
idea
import
cholesterol
host
cell
membran
factor
influenc
propag
mani
virus
previou
work
uncov
imbalanc
cellular
cholesterol
homeostasi
import
factor
iav
particl
product
plasma
membran
infect
releas
viral
particl
report
accumul
cholesterol
lel
interfer
iav
infect
much
earlier
stage
ie
step
endosom
escap
line
previou
report
show
antivir
ifn
lead
upregul
concomit
lel
cholesterol
accumul
importantli
elev
lel
cholesterol
pool
independ
ifn
via
overexpress
pharmacolog
inhibit
antivir
consequ
even
express
abolish
target
genom
edit
induct
interferon
system
univers
element
activ
host
cell
innat
immun
respons
virus
cell
sens
viral
compon
interferon
produc
infect
cell
secret
induc
antivir
state
surround
cell
thu
keep
viral
spread
bay
among
host
cell
protein
induc
interferon
potent
antivir
factor
strongli
restrict
iav
antivir
activ
mechanist
fulli
resolv
detect
lel
report
previous
induc
accumul
lel
cholesterol
possibl
interf
erlel
contact
site
although
impact
membran
fusion
observ
sever
studi
role
lel
cholesterol
accumul
part
antivir
activ
question
lel
cholesterol
accumul
observ
cell
issu
whether
ifn
treatment
would
also
result
upregul
lel
cholesterol
content
via
upregul
rather
independ
whether
ifndriven
increas
lel
cholesterol
level
would
restrict
iav
endosom
escap
address
previous
report
ifn
treatment
inde
elev
amount
lel
cholesterol
interestingli
increas
level
lel
cholesterol
upon
ifn
treatment
suggest
earlier
shown
experiment
ifndriven
lel
cholesterol
increas
appear
depend
upregul
line
previou
data
obtain
cell
ectop
overexpress
also
note
strike
reposit
lel
ifn
treatment
depend
increas
lel
cholesterol
content
could
mimick
cell
forc
cholesterol
load
lel
result
clearli
demonstr
depend
lel
posit
lel
cholesterol
content
antivir
impact
lel
cholesterol
overload
iav
cell
entri
heavili
disput
util
overexpress
smallmolecul
inhibitor
interfer
proper
function
endosom
cholesterol
transport
approach
repres
altern
ifnindepend
wellestablish
model
use
induc
lel
cholesterol
accumul
review
refer
identifi
interferonindepend
lel
cholesterol
accumul
clearli
antivir
restrict
earli
iav
infect
cell
expos
thu
support
idea
lel
cholesterol
element
ifn
respons
chain
discov
entri
factor
filovirus
case
ebola
viru
entri
appar
act
cholesterolindepend
fashion
find
indic
overexpress
per
se
increas
proport
iavinfect
cell
argu
howev
cholesterolindepend
function
iav
entri
significantli
impair
number
npposit
nuclei
seen
infect
cell
well
cell
indic
earli
iav
infect
affect
earlier
analysi
et
al
detect
decreas
np
stain
use
similar
cell
system
howev
known
whether
lel
cholesterol
phenotyp
appar
stabl
cell
line
virus
iav
still
abl
reach
acid
endosom
site
phdepend
viral
envelopemembran
fusion
occur
agreement
observ
inhibit
iav
uptak
judg
presenc
iav
protein
traffick
cell
like
envelop
virus
iav
exploit
drop
ph
encount
lel
trigger
viral
envelopeendosom
membran
fusion
turn
lead
cytosol
releas
viral
genom
low
ph
induc
insert
ha
fusion
peptid
endosom
membran
pull
two
membran
togeth
two
bilay
merg
partial
hemifus
eventu
fuse
complet
therebi
creat
expand
fusion
pore
iav
low
ph
suffici
trigger
fusion
process
although
impair
endosom
acidif
link
lel
cholesterol
imbal
observ
signific
alter
lel
ph
amount
ha
underw
fusionact
conform
chang
cell
impair
function
indic
chang
lipid
composit
target
membran
compromis
endosom
acidif
like
caus
impair
fusion
viral
envelop
endosom
membran
lel
typic
pleiomorph
contain
intralumin
vesicl
within
limit
membran
endosom
cholesterol
overload
report
impair
intraendosom
membran
traffick
ie
backfus
intralumin
vesicl
limit
membran
accordingli
infect
vesicular
stomat
viru
vsv
viru
first
fuse
intralumin
vesicl
releas
viral
genom
via
backfus
nucleocapsidcontain
intern
vesicl
impair
cell
forc
accumul
late
endosom
cholesterol
observ
strikingli
neg
impact
increas
lel
cholesterol
level
virusendosom
lipid
mix
thu
hemi
fusion
viral
envelop
endosom
membran
impair
notabl
acid
bypassinduc
iav
fusion
plasma
membran
circumv
passag
lel
compart
affect
underscor
fact
defect
endosom
escap
caus
iav
entri
inhibit
cell
display
elev
lel
cholesterol
level
interestingli
inhibit
iav
hamedi
hemifus
report
upon
overexpress
although
attribut
higher
lipid
order
host
membran
potenti
involv
elev
cholesterol
content
investig
howev
sinc
cellcel
fusion
assay
use
haexpress
cell
use
studi
possibl
actual
hamedi
viral
envelopeendosom
membran
fusion
fulli
reproduc
hamedi
membran
fusion
address
mani
studi
employ
biophys
approach
special
attent
paid
role
cholesterol
process
see
refer
overview
membran
fusion
dynam
influenc
lipid
composit
host
cell
target
membran
viral
envelop
vitro
liposom
studi
reflect
neither
membran
curvatur
exact
lipid
protein
composit
endosom
focus
impact
increas
lel
cholesterol
level
observ
certain
physiolog
condit
ie
ifnmedi
antivir
respons
free
cholesterol
within
lel
thought
diffus
preferenti
membran
intralumin
vesicl
endocytos
iav
particl
might
also
incorpor
excess
cholesterol
viral
envelop
might
turn
disturb
proper
ha
mobil
andor
function
support
idea
moder
level
remov
cholesterol
iav
envelop
shown
enhanc
fusion
iav
fusion
peptid
hairpin
structur
chang
lipid
composit
target
membran
might
interfer
proper
insert
also
highli
like
lel
cholesterol
enrich
affect
curvatur
andor
rigid
endosom
membran
caus
restrict
fusion
capac
data
present
studi
contradict
previou
studi
report
lel
cholesterol
accumul
reduc
iav
endosom
escap
cell
detect
effect
virusmembran
hemifus
lead
assumpt
excess
lel
cholesterol
mechan
inhibit
iav
fusion
similarli
minor
impact
lipid
mix
observ
lel
compart
subject
cholesterol
load
use
howev
studi
mention
pseudoviru
infect
use
importantli
comparison
differ
method
use
measur
lipid
mix
singl
dye
versu
dual
dye
indic
singledy
fusion
assay
might
reduc
sensit
consist
alway
detect
pronounc
decreas
hemifus
cell
appli
wellestablish
dualdy
assay
thu
result
point
inhibitori
effect
lel
cholesterol
viral
envelopeendosom
membran
fusion
besid
activ
respect
lel
cholesterol
content
propos
affect
iav
endosom
escap
step
later
hemifus
possibl
neg
affect
fusion
pore
format
open
observ
impair
membran
fusion
cell
treat
interferon
downregul
yet
number
infect
cell
increas
observ
suggest
sever
role
complex
process
iav
endosom
escap
addit
cholesterolmedi
inhibit
hemifus
turn
could
explain
fact
rescu
due
overexpress
overexpress
cell
seen
earlier
studi
ifninduc
antivir
effector
control
viral
replic
ie
act
stage
viru
genom
alreadi
found
cytoplasm
importantli
cholesterol
axi
identifi
effici
interfer
cytosol
entri
incom
viral
particl
earli
step
infect
cycl
impair
transfer
viral
genom
cytoplasm
might
provid
host
cell
time
mount
antivir
respons
taken
togeth
data
establish
lel
cholesterol
balanc
function
relev
effector
act
earli
antivir
barrier
lel
cholesterolmedi
restrict
embed
antivir
respons
mount
upon
exposur
host
cell
function
ifncontrol
switch
precis
modul
cholesterol
step
incom
iav
might
combin
reduc
primari
infect
fewer
side
effect
therefor
could
open
novel
antivir
approach
target
host
factor
compon
lel
cholesterol
level
might
serv
like
host
target
human
epitheli
carcinoma
cell
line
stabli
express
provid
grewal
sydney
describ
previous
wildtyp
cell
provid
grewal
sydney
cell
human
alveolar
epitheli
cell
line
provid
ludwig
muenster
cultiv
dulbecco
modifi
eagl
medium
dmem
madindarbi
canin
kidney
mdckii
cell
provid
ludwig
muenster
cultur
minim
essenti
medium
mem
cell
cultur
media
supplement
fetal
bovin
serum
merck
catalog
uml
penicillin
mgml
streptomycin
cell
cultur
atmospher
ifn
pretreat
cell
expos
ngml
recombin
human
interferon
beta
immunotool
catalog
h
cell
line
transfect
plasmid
use
lipofectamin
invitrogen
accord
manufactur
protocol
kindli
provid
jacob
yount
addgen
plasmid
number
human
express
plasmid
murin
express
plasmid
serv
control
knock
cell
use
gene
edit
plasmid
santa
cruz
plasmid
cotransfect
hdr
plasmid
ko
cell
posit
select
puromycincontain
select
medium
basal
express
ifninduc
express
wt
cell
compar
western
blot
use
antibodi
proteintech
catalog
verifi
ifn
signal
affect
ko
cell
ifnmedi
induct
monitor
western
blot
cell
signal
catalog
detect
gapdh
dehydrogenas
santa
cruz
catalog
serv
control
confirm
equal
level
protein
load
sirna
human
smart
pool
sigenom
human
sirna
ge
dharmacon
use
knockdown
protein
express
cell
nontarget
sirna
ontarget
plu
sicontrol
ge
dharmacon
serv
neg
control
iav
strain
apuerto
obtain
viru
strain
collect
institut
virolog
univers
muenster
muenster
germani
iav
strain
provid
thorsten
wolff
robert
koch
institut
berlin
germani
iav
strain
propag
mdckii
cell
infect
cell
wash
phosphatebuff
salin
pb
expos
indic
multipl
infect
moi
viru
dilut
pb
bovin
serum
albumin
bsa
sigma
catalog
mm
mm
uml
penicillin
mgml
streptomycin
pbsbsa
ice
otherwis
indic
inoculum
aspir
min
cell
wash
pb
incub
dmem
bsa
uml
penicillin
mgml
streptomycin
dmemba
respect
period
time
cell
grown
coverslip
fix
paraformaldehyd
pfa
pb
min
room
temperatur
cholesterol
stain
cell
incub
filipin
filipin
complex
streptomyc
filipinensi
sigma
catalog
stock
mgml
dimethyl
sulfoxid
dmso
bsa
h
visual
endosomallysosom
compart
cell
incub
either
nm
lysotrack
red
molecular
probe
h
prior
fixat
antibodi
santa
cruz
catalog
tetramethylrhodamin
tmr
isocyan
tritc
bsa
h
filipin
stain
confoc
microscopi
perform
use
lsm
microscop
carl
zeiss
inc
jena
germani
equip
planapochromat
oil
immers
object
zstack
individu
cell
subject
threshold
process
mander
coloc
coeffici
respect
endosomallysosom
marker
filipin
signal
analyz
use
imagej
plugin
jacop
addit
number
voxel
posit
filipin
lysotrack
filipin
relat
total
number
lysotrackerposit
voxel
regardless
intens
filipin
signal
strength
gener
heat
map
present
filipin
stain
differ
filipin
pixel
intens
colorcod
accord
gradient
present
color
lookup
tabl
lut
gradient
color
rang
blue
lowest
intens
white
highest
intens
analyz
cluster
acid
endosom
grayscal
imag
process
binari
manner
replac
lysotrack
intens
valu
global
determin
threshold
valu
set
valu
help
imagej
plugin
collect
biovoxxel
toolbox
result
binari
imag
use
determin
number
neighbor
endosom
individu
cell
data
express
frequenc
distribut
least
cell
per
condit
protein
sampl
prepar
cell
wash
pb
harvest
urea
subject
sonic
protein
concentr
lysat
determin
bradford
method
primari
antibodi
use
detect
respect
protein
sdspage
western
blot
antiannexin
vi
antibodi
santa
cruz
catalog
antigapdh
antibodi
santa
cruz
catalog
antibodi
proteintech
antibodi
proteintech
antiinfluenza
antibodi
clone
abd
serotec
antibodi
clone
sigma
catalog
irdy
secondari
antibodi
licor
label
nearinfrar
nir
fluoresc
dye
use
direct
nonenzymat
detect
primari
antibodi
coupl
irdy
irdy
donkey
antimous
igg
hl
donkey
antirabbit
igg
hl
donkey
antigoat
igg
hl
odyssey
infrar
imag
system
licor
use
nir
fluoresc
detect
western
blot
quantifi
use
odyssey
infrar
imag
system
softwar
version
cell
pretreat
indic
respect
figur
legend
seed
cover
slip
day
prior
infect
infect
standard
procedur
describ
h
pi
cell
fix
min
permeabil
triton
min
block
overnight
stain
antinp
antibodi
mous
antiinfluenza
viru
nucleoprotein
clone
abd
serotec
h
antimous
alexa
fluor
donkey
antimous
igg
hl
secondari
antibodi
alexa
fluor
invitrogen
catalog
h
dapi
sigma
done
use
bsa
transfect
cell
identifi
confoc
microscopi
use
lsm
microscop
carl
zeiss
inc
jena
germani
equip
planapochromat
oil
immers
object
categor
presenc
absenc
distinct
iav
np
signal
appli
assay
establish
previous
stauffer
et
al
prior
infect
cell
preincub
bafilomycin
cayman
catalog
nm
viru
prime
h
dmem
adjust
ph
me
morpholineethanesulfon
acid
mm
cell
infect
moi
prime
viru
h
ice
subsequ
wash
twice
cold
dmemba
acid
bypass
achiev
incub
lowph
dmem
mm
citrat
ph
min
follow
two
wash
step
cold
dmemba
dmemba
contain
bafilomycin
nm
ad
cell
incub
h
fluorescenceactiv
cell
sorter
fac
analysi
cell
harvest
accutas
treatment
millipor
catalog
fix
formaldehyd
min
permeabil
use
triton
min
block
well
stain
antinp
antibodi
mous
antiinfluenza
viru
nucleoprotein
clone
abd
serotec
h
antimous
alexa
fluor
donkey
antimous
igg
secondari
antibodi
alexa
fluor
invitrogen
catalog
h
done
use
cell
wash
three
time
block
antibodi
incub
total
cell
analyz
per
sampl
uninfect
cell
cell
without
bypass
serv
control
earli
detect
virusassoci
protein
monitor
iav
intern
perform
previous
describ
briefli
cell
infect
moi
min
describ
standard
infect
procedur
cell
wash
acid
pb
pbshcl
ph
remov
nonintern
virion
outsid
cell
subsequ
cell
wash
twice
pb
incub
dmemba
indic
time
cell
lyse
analyz
western
blot
iav
protein
load
control
detect
ha
acidinduc
conform
chang
perform
describ
previous
antibodi
specif
recogn
ha
undergon
acidinduc
conform
chang
haac
kindli
provid
yohei
yamauchi
eth
lel
membran
fraction
enrich
via
sucros
densiti
gradient
centrifug
describ
previous
cholesterol
quantifi
via
use
amplex
red
cholesterol
assay
kit
invitrogen
describ
earlier
ratiometr
fluoresc
microscopi
calcul
endosom
ph
done
describ
johnson
et
al
briefli
cell
puls
min
oregon
green
label
tetramethylrhodamin
tmr
label
dextran
invitrogen
kda
follow
chase
cell
wash
kept
hepesbuff
hank
balanc
salt
solut
hbss
imag
acquisit
epifluoresc
signal
acquir
dye
individu
interv
gener
calibr
curv
base
mean
fluoresc
ratio
respect
ph
standard
solut
rang
ph
appli
basal
measur
endosom
ph
calcul
calibr
curv
viru
lipid
label
use
oxacarbocyanin
molecular
probe
catalog
octadecyl
rhodamin
b
chlorid
molecular
probe
catalog
describ
previous
adapt
singl
use
molecular
probe
catalog
brief
iav
label
final
concentr
respect
alon
h
room
temperatur
subsequ
filter
filter
millipor
cell
infect
label
viru
min
ice
wash
twice
pb
subsequ
incub
indic
period
time
cell
harvest
accutas
millipor
catalog
treatment
fix
formaldehyd
min
lipid
mix
quantifi
fac
analysi
cell
analyz
per
sampl
linear
regress
analysi
graphpad
prism
use
determin
bestfit
linear
regress
calcul
slope
priori
power
analysi
g
power
use
estim
sampl
size
requir
detect
moder
strong
effect
data
given
mean
standard
deviat
sem
statist
signific
result
evalu
unpair
student
test
analysi
varianc
anova
oneway
twoway
follow
tukey
multiplecomparison
test
use
graphpad
prism
version
graphpad
softwar
inc
san
diego
ca
